Form 4: Marimed Director Kathleen Tucker Converts Restricted Stock Units to 75,000 Common Shares

Marimed Inc. Director Kathleen Tucker has increased her direct beneficial ownership of the company's common stock by 75,000 shares through the conversion of previously granted Restricted Stock Units (RSUs).

Summary

• Kathleen Tucker, a Director of Marimed Inc. (MRMD), reported a change in beneficial ownership of the company's securities.
• On June 6, 2025, Ms. Tucker acquired 75,000 shares of common stock through the exercise or conversion of derivative securities.
• The transaction involved the conversion of Restricted Stock Units (RSUs) into common stock on a one-for-one basis, with an acquisition price of $0 per share.
• These RSUs were granted on June 6, 2024, and vested in full on June 6, 2025, as per an agreement between Marimed and Ms. Tucker.
• Following this transaction, Kathleen Tucker directly beneficially owns 350,000 shares of Marimed Inc. common stock.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as it reflects a routine, pre-planned increase in a director's direct ownership through equity compensation, which generally aligns management interests with shareholders. It is not highly impactful but is a positive signal of insider commitment.

Positives

• The conversion of RSUs into common stock increases the direct ownership stake of a company director, aligning their interests more closely with those of shareholders.
• The vesting and conversion of RSUs indicate the fulfillment of compensation agreements, which can be a sign of stable corporate governance and compensation practices.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic outlook.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, common across all industries, reflecting the vesting and conversion of equity compensation for a director. It does not provide specific insights into broader industry trends for the cannabis sector in which Marimed operates.

Related Party Transactions

• The transaction involves the conversion of Restricted Stock Units (RSUs) granted by the Issuer to a director, which is a common form of equity compensation and a routine related-party transaction.

Stakeholder Impact

• Shareholders: The increase in a director's direct stock ownership aligns their financial interests more closely with those of public shareholders, potentially fostering greater commitment to long-term company performance.

Key Dates

Keywords

Marimed Inc., MRMD, Kathleen Tucker, Form 4, Insider Transaction, Restricted Stock Units, RSU Conversion, Common Stock, Beneficial Ownership, Director Ownership